Generic placeholder image

Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1573-4064
ISSN (Online): 1875-6638

Research Article

Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives

Author(s): Almeqdad Y. Habashneh, Mustafa M. El-Abadelah, Sanaa K. Bardaweel and Mutasem O. Taha*

Volume 14, Issue 5, 2018

Page: [468 - 477] Pages: 10

DOI: 10.2174/1573406414666171204143157

Price: $65

Abstract

Background: Amidrazones have been reported to have significant anti-tumor properties against several cancer cell lines.

Objectives: The current project aims to profile the structure-anticancer activity relationship of phenyl-amidrazons.

Methods: Fifteen phenyl-amidrazone-piperazine derivatives were prepared and tested against four cancer cell lines (leukemia, prostate, breast and colon cancers).

Results: Six compounds illustrated low micromolar anticancer IC50 values, while the remaining compounds were either inactive or of moderate potencies. All compounds were virtually nontoxic against normal fibroblast cells.

Conclusion: Docking into the oncogenic kinase bcr/abl illustrated the critical importance of (i) phalogen substituent on the ligand's phenyl ring and (ii) the presence of positive ionizable moiety at the ligand's piperazine fragment for anticancer activity.

Keywords: Aryl-amidrazones, anticancer bioactivity, docking, SAR, electrostatic attraction, hydrogen bonding.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy